Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Will Comet C/2025 R3 (PanSTARRS) be the 'great comet' of 2026? - 2Jupiter and the moon take a sunset stroll on March 26. Here's how to see it
- 3Israeli archaeologists launch project to trace origins of ancient pottery
- 4The most effective method to Use an Internet Showcasing Degree for Advanced Predominance
- 5The Most Enrapturing Authentic Milestones to Visit
- Southern Californians, your health insurance costs could rise in 2026
- Abbott issues US device correction for some glucose monitors over faulty readings risk
- 'Hero' who wrestled gun from Bondi shooter named as Ahmed al Ahmed
- Haunting Giant Squid Surfaces in Japan and Devours Its Prey (Video)
- South Korea to End Bear Bile Farming and Find New Homes for the 200 Bears Stuck in the Industry
- How a toxic self-improvement trend with a funny name took over your feed
- What to know about new CDC deputy director who has been critical of COVID vaccines
- Experience Sports in Dubai: A Daredevil's Aide
- Chinese construction workers in Israel: 'I’d rather be bombed than live in poverty'
